BriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created "SpinCo" Entity whereby Shareholders to Receive One New Share of "SpinCo" in Addition to Each Current Share of BriaCell Already Held
Stock Information for BriaCell Therapeutics Corp.
Loading
Please wait while we load your information from QuoteMedia.